Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

PRIZM announces gene targeting results

April 25, 1997

MiniMed and Trimeris collaborate to deliver HIV therapy

April 25, 1997

Disposition of AR-177

April 23, 1997

Bayer discloses antiretroviral agents

April 23, 1997

Orally bioavailable cyclic HIV protease inhibitors with low potential for drug resistance

April 22, 1997

U.S. patent approval for Theratechnologies' antisense therapy

April 22, 1997

FDA clears Epivir under traditional regulations; clinical benefit confirmed

April 22, 1997

Preclinical results reveal mechanism of action and resistance profile of GEM-91

April 21, 1997

Immtech obtains exclusive rights to novel antimicrobial pharmaceutical compounds

April 17, 1997

Genesys Pharma/Novopharm Biotech agreement provides funding for antisense drug for AIDS

April 17, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 3, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...